Does single application of topical chloramphenicol to high risk sutured wounds reduce incidence of wound infection after minor surgery? Prospective randomised placebo controlled double blind trial

BMJ (Online)

Volumn 338, Issue 7688, 2009, Pages 211-214

  Heal, Clare F ^a   Buettner, Petra G ^a   Cruickshank, Robert ^b   Graham, David ^b   Browning, Sheldon ^c   Pendergast, Jayne ^b   Drobetz, Herwig ^d   Gluer, Robert ^a   Lisec, Carl ^e  

^a JAMES COOK UNIVERSITY   (Australia)

^b Walkerston Medical Centre   (Australia)

^c Molescan   (Australia)

^d MACKAY BASE HOSPITAL   (Australia)

^e TOWNSVILLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; PARAFFIN; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; AUSTRALIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SKIN SURGERY; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; WOUND INFECTION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; FEMALE; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SKIN TUMOR; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; SUTURING METHOD; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTIC PROPHYLAXIS; CHLORAMPHENICOL; DOUBLE-BLIND METHOD; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SKIN NEOPLASMS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURGICAL WOUND INFECTION; SUTURE TECHNIQUES; TREATMENT OUTCOME;

EID: 61849156975     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.a2812     Document Type: Article

References (36)

1. Allen LV. Compounding gels. Secundum Artem. 2007;4(5) (available at www.picosearch.com/cgi-bin/ts.pl?index=406555&query=Gel&SEARCH=GO).
2. Pfizer.Product information: Chloromycetin eye ointment. Pfizer, 2005 (available at www.pfizer.com.au/ProductInfo.aspx).
3. Therapeutic guidelines: antibiotic. Version 13. North Melbourne, Victoria: Therapeutic Guidelines, 2006.
4. Erel E, Platt A, Ramakrishnan V. Chloramphenicol use in plastic surgery. Br J Plast Surg 1999;52:326-7.
5. Pasapula C, Strick M. The use of chloramphenicol ointment as an adhesive for replacement of the nail bed after simple nail bed repairs. J Hand Surg (Br) 2004;29:634-5.
6. Kamath S, Sinha S, Shaari E, Young D, Campbell AC. Role of topical antibiotics in hip surgery: a prospective randomised study. Injury 2005;36:783-7.
7. Rayner SA, Buckley RJ. Ocular chloramphenicol and aplastic anaemia: is there a link? Drug Saf 1996;14:273-6.
8. Laporte J-R, Vidal X, Ballarin E, Ibanez L. Possible association between ocular chloramphenicol and aplastic anaemia - the absolute risk is low. Br J Clin Pharmacol 1998;46:181-4.
9. Heal C, Buettner P, Raasch, Browning S, Graham D, Campbell M, et al. "Can sutures get wet?" A randomised controlled trial of wound management in general practice. BMJ 2006;332:1053-4.
10. Heal C, Buttner P, Browning S. Risk factors for infection after minor surgery in general practice. Med J Aust 2006;185:255-9.
11. Lathlean S. Skin cancer in general practice in South Australia. Aust Fam Physician 1999;28(supp 1):S28-31.
12. Dixon AJ, Dixon MP, Askew DA, Wilkinson D. Prospective study of wound infections in dermatological surgery in the absence of prophylactic antibiotics. Dermatol Surg 2006;32:826-7.
13. Amici J, Rogues A, Lasheras A, Gachi JP, Guillot P, Beylot C. A prospective study of the incidence and complications associated with dermatological surgery. Br J Dermatol 2005;153:967-71.
14. Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index: National Nosocomial Infections Surveillance System. Am J Med 1991;91:152-7S.
15. Haas AF, Grekin RC. Antibiotic prophylaxis in dermatological surgery. J Am Acad Dermatol 1995;32:155-76.
16. Cruse JE, Foord R. The epidemiology of wound infection. Surg Clin North Am 1980;60:27-39.
17. Platt R. Antibiotics prophylaxis in clean surgery: does it work? Should it be used if it does? New Horiz 1998;6(2 suppl):s53-7.
18. Heal C, Buttner P, Raasch B, Browning S. Minor skin excisions in general practice in north Queensland. Aust Fam Physician 2006;35:825-8.
19. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for the prevention of surgical site infection. Infect Control Hosp Epidemiol 1999;20:247-78.
20. Bruce J, Russell EM, Mollison J, Krukowski ZH. The quality of measurement of surgical wound infection as a basis for monitoring: a systematic review. J Hosp Infec 2001;49:99-108.
21. Edwards PS, Lipp A, Holmes A. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev 2004;(3):CD003949.
22. Australian Bureau of Statistics. Census of population and housing, basic community profiles. 2006. www.abs.gov.au/.
23. Australian Government, Bureau of Meteorology. Climate data online. 2008. www.bom.gov.au/climate/averages/#climatemaps.
24. Edlich RF. Biochemical and clinical aspects. In: Cohen IK, Diegelman RF, Lindblad WJ, eds. Wound healing. Sydney: WB Saunders, 1992:581-600.
25. Thomas S. Wound management and dressings. London: The Pharmaceutical Press, 1990:9-19.
26. Colebrook L, Hood AM. Infection through soaked dressings. Lancet 1948;2:682-3.
27. British Medical Association, Royal Pharmaceutical Society of Great Britain. British national formulary. London: BMA, RPS, 2006:605-6 (No 52).
28. Leyden JJ, Kligman AM. Contact dermatitis to neomycin sulfate. JAMA 1979;242:1276-8.
29. Bradley SF, Ramsey MA, Morton TM, Kauffman CA. Mupirocin resistance: clinical and molecular epidemiology. Infect Control Hosp Epidemiol 1995;16:354-8.
30. Miller MA, Dascal A, Portnoy J, Mendersen J. Development of mupirocin resistance among MRSA after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996;17:811-3.
31. Fukuda M, Ohashi H, Matsumoto C, Mishima S, Shimomura Y. Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops. Cornea 2002;21(7 suppl):S86-9.
32. Marks JG, Belsiion DV, DeLeo VA, Fowler JF, Fransway AF, Maibach HI, et al. North American contact dermatitis group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol 1998;38:911-8.
33. Blondeel A, Oleffe J, Achten G. Contact allergy in 330 dermatological patients. Contact Dermatitis 1978;4:270-6.
34. Buckley S. Survey of patients taking topical medication at their first presentation to eye casualty. BMJ 1999;300:1497-8.
35. Messingham MJ, Arpey CJ. Update on the use of antibiotics in cutaneous surgery. Dermatol Surg 2005;31:1068-78.
36. Cho CY, Lo JS. Dressing the part. Dermatol Clin 1998;16:25-47.